Cell-Penetrating Peptides

It’s notoriously difficult to engineer a molecule to pass through a cell membrane.


By their nature, peptides can pass into cells more easily than other molecules. This ability can be harnessed to design short positively-charged peptides for traversing cell membranes, and transporting key molecules alongside them.


Instead of inventing over-complicated strategies to force incompatible molecules past an impenetrable cell membrane, peptides provide the ultimate shortcut into a cell. 

Peptides Transport Molecules into Cells

Cell-penetrating peptides can be conjugated to a virtually limitless variety of molecules to transport them inside of a cell. These can include oligonucleotides, RNA, therapeutic proteins, and even other peptides.

While researchers and industry professionals work on new applications and techniques for delivering their target molecules into cells, we work on the custom cell-penetrating peptides.

Custom Peptide Design

Optimising peptides for cell intrusion requires vast expertise and experience. Mimotopes has been operating at the forefront of peptide chemistry for over 30 years, supporting researchers worldwide.

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

✉ useast@mimotopes.com

✉ uswest@mimotopes.com



asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com


UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

  ✉ useast@mimotopes.com 
  ✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK/ Europe/ Africa/ Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Medicine in outer spaceGo to article: In this issueGo to article: ContentsGo to article: CSafeAPSGo to article: AgilentGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Allpack group agGo to article: CommentGo to article: Sandoz spin-off continues Novartis’ focus on innovationGo to article: High risk, high reward – the future of CAR-T therapy in CLLGo to article: bluebird bio bags landmark FDA approvals for gene therapiesGo to article: Covid-19 vaccine companies boosted with over 80% revenue growthGo to article: Urgent need to update Canada’s breast cancer screening guidelinesGo to article: The epidemiology of RSV changed in UK children during the pandemic Go to article: Zenatek Company Insight Go to article: BEA TechnologiesGo to article: In DepthGo to article: Medicine in outer space: drug development, manufacturing, and beyondGo to article: Oncology therapies dominate the orphan drug landscapeGo to article: How environmental factors could influence disease and drugsGo to article: Joining the dots: How gene regulatory network tools are unearthing drugsGo to article: Inflation drives pharma manufacturing focus on sustainability Go to article: What do remote assessments mean for sponsors?Go to article: CMO Moves: Regulatory catalysts for drug manufacturing-OctoberGo to article: TripletreeGo to article: In DataGo to article: Data analytics hiring levels in the pharma industry fell to a year-low in AugustGo to article: Pharma found it easier to fill cloud vacancies in Q2 of 2022Go to article: Pharma filings see a 56% increase in big data mentions since Q2 of 2021Go to article: Industrial automation hiring levels in pharma rose in August 2022Go to article: EventsGo to article: Next issue